Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

3.35
Delayed Data
As of Sep 30
 +0.12 / +3.72%
Today’s Change
2.58
Today|||52-Week Range
5.35
-5.37%
Year-to-Date
ARIAD (ARIA) Leukemia Drug Iclusig Gets Approval in Japan
Sep 30 / Zacks.com - Paid Partner Content
When You Should (and Shouldnt) Panic Over Earnings Results
Sep 28 / MotleyFool.com - Paid Partner Content
The Highest-Yielding Drug Stocks
Sep 29 / MotleyFool.com - Paid Partner Content
Will PDL BioPharma (PDLI) Continue to Surge Higher?
Sep 20 / Zacks.com - Paid Partner Content